{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:42:16Z","timestamp":1794120136824,"version":"4.8.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The National Key Research and Development Program of China","award":["2016YFC1306202"],"award-info":[{"award-number":["2016YFC1306202"]}]},{"name":"Wuhan Science and Technology Innovation Platform-Children Nerve Disease Clinical Medical Research Center Funded Projects","award":["2014-160"],"award-info":[{"award-number":["2014-160"]}]},{"name":"A Multicenter Clinical Study of Ketogenic Diet in the Treatment of Mitochondrial Epilepsy","award":["FTCSF-2018-05"],"award-info":[{"award-number":["FTCSF-2018-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Short-chain enoyl-CoA hydratase (ECHS1) is a multifunctional mitochondrial matrix enzyme involved in the second step of mitochondrial fatty acid \u03b2-oxidation. Mitochondrial diseases resulting from <jats:italic>ECHS1<\/jats:italic> mutations are often characterised by encephalopathy, deafness, epilepsy, optic atrophy, cardiomyopathy, dystonia, and lactic acidosis. In this study, we report two novel heterogeneous variants, c.414\u2009+\u20095G\u2009&gt;\u2009A (in intron 3) and c.310C\u2009&gt;\u2009G (in CDS), of <jats:italic>ECHS1<\/jats:italic> in an infant with mitochondrial encephalopathy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The two novel variants, c.414\u2009+\u20095G\u2009&gt;\u2009A (Chr10:135183403) in intron 3 and c.310C\u2009&gt;\u2009G (Chr10:135183512) in CDS, were identified by next generation sequencing (NGS). A minigene assay was used to analyse the function of the c.414\u2009+\u20095G\u2009&gt;\u2009A variant. ECHS1 enzyme activity was measured by spectrophotometry in the patient-derived myoblasts. The 2-year old patient presented with mitochondrial encephalopathy since birth. Clinical features were encephalopathy, epilepsy, and hindered psychomotor and language development. Serum lactate and blood ammonia levels were elevated, and brain magnetic resonance imaging showed abnormal signals in the bilateral frontal, parietal, and occipital cortices and brainstem and basal ganglia. We found two novel heterogeneous variants in <jats:italic>ECHS1<\/jats:italic> in this patient. Minigene assay revealed the c.414\u2009+\u20095G\u2009&gt;\u2009A variant as the cause of intronic cryptic splice site activation and 39\u2009bp deletion in mature mRNA. In silico analysis predicted that c.310C\u2009&gt;\u2009G might change glutamine (Q) to glutamic acid (E) in the 104th amino acid sequence (p.Q104E). To investigate the impact of these two variants on protein function, we constructed a 3D model of human ECHS1 and showed that the variants might alter the highly conserved region in close proximity to the active site, which might hinder, or even halt, enzymatic activity. The experimental assay showed that ECHS1 enzyme activity in the patient-derived myoblasts decreased compared to that in control.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings are the first to report a mitochondrial encephalopathy infant carrying two novel <jats:italic>ECHS1<\/jats:italic> variants, c.414\u2009+\u20095G\u2009&gt;\u2009A and c.310C\u2009&gt;\u2009G, which might be deleterious variants, function as pathogenicity markers for mitochondrial encephalopathy, and facilitate disease diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-020-01735-y","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T12:02:45Z","timestamp":1588248165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Two novel ECHS1 variants, affecting splicing and reducing enzyme activity, is associated with mitochondrial encephalopathy in infant: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Miaojuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhisheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"1735_CR1","doi-asserted-by":"crossref","unstructured":"Sharpe AJ, McKenzie M. Mitochondrial fatty acid oxidation disorders associated with short-chain Enoyl-CoA Hydratase (ECHS1) deficiency. Cells. 2018;7(6).","DOI":"10.3390\/cells7060046"},{"issue":"3","key":"1735_CR2","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1006\/geno.1996.4597","volume":"40","author":"U Janssen","year":"1997","unstructured":"Janssen U, Davis EM, Le Beau MM, Stoffel W. Human mitochondrial enoyl-CoA hydratase gene (ECHS1):structural organization and assignment to chromosome 10q26. 2\u2013q26. 3. Genomics. 1997;40(3):470\u20135.","journal-title":"Genomics."},{"issue":"4","key":"1735_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/cge.12891","volume":"91","author":"F Al Mutairi","year":"2017","unstructured":"Al Mutairi F, Shamseldin HE, Alfadhel M, Rodenburg RJ, Alkuraya FS. A lethal neonatal phenotype of mitochondrial short-chain enoyl-CoA hydratase-1 deficiency. Clin Genet. 2017;91(4):629\u201333.","journal-title":"Clin Genet"},{"key":"1735_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ymgmr.2014.10.003","volume":"1","author":"K Yamada","year":"2014","unstructured":"Yamada K, Naiki M, Hoshino S, Kitaura Y, Kondo Y, Nomura N, Kimura R, Fukushi D, Yamada Y, Shimozawa N, Yamaguchi S, Shimomura Y, Miura K, Wakamatsu N. Clinical and biochemical characterization of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency that causes Leigh-like disease and ketoacidosis. Mol Genet Metab Rep. 2014;1:455\u201360.","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"1735_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/humu.23348","volume":"39","author":"PJ Freeman","year":"2018","unstructured":"Freeman PJ, Hart RK, Gretton LJ, Brookes AJ, Dalgleish R. Variant validator: accurate validation, mapping, and formatting of sequence variation descriptions. Hum Mutat. 2018;39(1):61\u20138.","journal-title":"Hum Mutat"},{"issue":"9","key":"1735_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37(9):e67.","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"1735_CR7","doi-asserted-by":"publisher","first-page":"W285","DOI":"10.1093\/nar\/gkm407","volume":"35","author":"RI Dogan","year":"2007","unstructured":"Dogan RI, Getoor L, Wilbur WJ, Mount SM. Splice Port\u2014an interactive splice-site analysis tool. Nucleic Acids Res. 2007;35(Web Server issue):W285\u201391.","journal-title":"Nucleic Acids Res"},{"key":"1735_CR8","unstructured":"The Berkeley Drosophila Genome Project (BDGP) is a consortium of the Drosophila Genome Center funded by the National Human Genome Research Institute and the National Institute of General Medical Sciences through its support of work in the Susan Celniker, J. Ben Brown, Erwin Frise and Gary Karpen laboratories. http:\/\/www.fruitfly.org\/."},{"issue":"2","key":"1735_CR9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0021-9258(17)32751-5","volume":"252","author":"JC Fong","year":"1977","unstructured":"Fong JC, Schulz H. Purification and properties of pig heart crotonase and the presence of short chain and long chain enoyl coenzyme a hydratases in pig and Guinea pig tissues. J Biol Chem. 1977;252(2):542\u20137.","journal-title":"J Biol Chem"},{"issue":"11","key":"1735_CR10","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.bcp.2011.07.103","volume":"82","author":"PB Lu\u00eds","year":"2011","unstructured":"Lu\u00eds PB, Ruiter JP, Ofman R, Ijlst L, Moedas M, Diogo L, Garcia P, de Almeida IT, Duran M, Wanders RJ, Silva MF. Valproic acid utilizes the isoleucine breakdown pathway for its complete beta-oxidation. Biochem Pharmacol. 2011;82(11):1740\u20136.","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"1735_CR11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/jmedgenet-2015-103231","volume":"52","author":"K Yamada","year":"2015","unstructured":"Yamada K, Aiba K, Kitaura Y, Kondo Y, Nomura N, Nakamura Y, Fukushi D, Murayama K, Shimomura Y, Pitt J, Yamaguchi S, Yokochi K, Wakamatsu N. Clinical, biochemical and metabolic characterisation of a mild form of human short-chain enoyl-CoA hydratase deficiency: significance of increased N-acetyl-S-(2-carboxypropyl) cysteine excretion. J Med Genet. 2015;52(10):691\u20138.","journal-title":"J Med Genet"},{"key":"1735_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/8904_2018_111","volume":"43","author":"CM Carlston","year":"2019","unstructured":"Carlston CM, Ferdinandusse S, Hobert JA, Mao R, Longo N. Extrapolation of variant phase in mitochondrial short-chain Enoyl-CoA Hydratase (ECHS1) deficiency. JIMD Rep. 2019;43:103\u20139.","journal-title":"JIMD Rep"},{"issue":"5","key":"1735_CR13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/acn3.189","volume":"2","author":"TB Haack","year":"2015","unstructured":"Haack TB, Jackson CB, Murayama K, Kremer LS, Schaller A, Kotzaeridou U, de Vries MC, Schottmann G, Santra S, B\u00fcchner B, Wieland T, Graf E, Freisinger P, Eggimann S, Ohtake A, Okazaki Y, Kohda M, Kishita Y, Tokuzawa Y, Sauer S, Memari Y, Kolb-Kokocinski A, Durbin R, Hasselmann O, Cremer K, Albrecht B, Wieczorek D, Engels H, Hahn D, Zink AM, Alston CL, Taylor RW, Rodenburg RJ, Trollmann R, Sperl W, Strom TM, Hoffmann GF, Mayr JA, Meitinger T, Bolognini R, Schuelke M, Nuoffer JM, K\u00f6lker S, Prokisch H, Klopstock T. Deficiency of ECHS1 causes mitochondrial encephalopathy with cardiac involvement. Ann Clin Transl Neurol. 2015;2(5):492\u2013509.","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"1735_CR14","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/ajmg.a.38658","volume":"176","author":"PE Fitzsimons","year":"2018","unstructured":"Fitzsimons PE, Alston CL, Bonnen PE, Hughes J, Crushell E, Geraghty MT, Tetreault M, O'Reilly P, Twomey E, Sheikh Y, Walsh R, Waterham HR, Ferdinandusse S, Wanders RJA, Taylor RW, Pitt JJ, Mayne PD. Clinical, biochemical, and genetic features of four patients with short-chain enoyl-CoA hydratase (ECHS1) deficiency. Am J Med Genet A. 2018;176(5):1115\u201327.","journal-title":"Am J Med Genet A"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01735-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-020-01735-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01735-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T23:12:48Z","timestamp":1619737968000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01735-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1735"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01735-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"6 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our present study protocol was approved by the Institutional Review Boards of the Wuhan Children\u2019s Hospital and performed in accordance with the Declaration of Helsinki. The family members provided written consent for themselves to participate in genetic analysis. The patient and his parents all agreed to publish this study via written consent. The consent was obtained from a parent of legal guardian of the patient. The consent was obtained from any other family members whose clinical details were discussed in this manuscript, in this section.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The family members provided written consent for themselves to participate in genetic analysis. The patient and his parents all agreed to publish this study via written consent. The consent was obtained from a parent of legal guardian of the patient. The consent was obtained from any other family members whose clinical details were discussed in this manuscript, in this section.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}